NCT04056338 is a clinical trial of No intervention in Intensive Care Unit Delirium, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

Who is sponsoring NCT04056338?

NCT04056338 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

What drugs are being tested in NCT04056338?

Interventions in NCT04056338: No intervention.

What condition does NCT04056338 study?

NCT04056338 studies Intensive Care Unit Delirium.

Is NCT04056338 still recruiting?

NCT04056338 is currently completed. Last updated 29 January 2021.

Last reviewed 2021-01-29 · How we verify

NCT04056338

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gut Microbiome and ICU Delirium Post Cardiac Surgeries

Completed Last updated 29 January 2021

What this trial tests

trial testing No intervention in Intensive Care Unit Delirium in 60 participants. Completed in 30 December 2019.

Timeline

1 January 2019

Primary endpoint
30 December 2019

30 December 2019

Quick facts

Lead sponsor	Second Affiliated Hospital, School of Medicine, Zhejiang University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	60
Start date	1 January 2019
Primary completion	30 December 2019
Estimated completion	30 December 2019
Sites	1 location across China

Drugs / interventions tested

No intervention

Conditions studied

Intensive Care Unit Delirium — all drugs for Intensive Care Unit Delirium →

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Who can join

Adults 18 to 90, any sex, with Intensive Care Unit Delirium. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

ICU delirium are assessed by clinical nurses twice every day. Delirious patients are matched with patients according to their disease, gender and age range(±3 years). Stool samples for gene sequencing are collected. Gut barrier function are studied with several serum biomarkers (endotoxin, etc.). Ecological analyses, regression models and mediation equation will be performed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Intensive Care Unit Delirium

Currently open trials in the same condition.

NCT07496255 — Virtual Reality Cognitive Intervention for Critically Ill Delirium Survivors (VR-Cog) · NA · recruiting
NCT06749483 — The Gut Microbiome - Source of Sepsis and Novel Target in Intensive Care Units? · recruiting
NCT06355570 — Delirium After Cardiac Surgery in Intensive Care Units · NA · recruiting
NCT05467410 — Optimal Timing of Computerized Cognitive Training for Older Intensive Care Unit Survivors · NA · active not recruiting
NCT06172491 — Automating Delirium Severity in the ICU · recruiting

Other Second Affiliated Hospital, School of Medicine, Zhejiang University trials

Trials by the same sponsor.

NCT07445152 — Research on Construction and Verification of Multimodal Medical Imaging Large Model · not yet recruiting
NCT06775665 — A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population · not yet recruiting
NCT07533422 — Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testing · NA · not yet recruiting
NCT07487285 — A Non-inferiority Study of Laser Combined With Ultrasonic Debridement Therapy (LCUDT) Versus Manual Combined With Ultras · NA · not yet recruiting
NCT07505186 — Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04056338 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital, School of Medicine, Zhejiang University
Last refreshed: 29 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04056338.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing